tiprankstipranks
Vistin Pharma ASA (GB:0RAM)
LSE:0RAM
UK Market
0RAM
Vistin Pharma ASA
RESEARCH TOOLSreports

Vistin Pharma ASA (0RAM) Financial Statements

0 Followers

Vistin Pharma ASA Financial Overview

Vistin Pharma ASA's market cap is currently kr849.20M. The company's EPS TTM is kr0.319; its P/E ratio is 12.04; Vistin Pharma ASA is scheduled to report earnings on August 20, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit$ 131.88M$ 142.94M$ 109.35M$ 90.46M$ 79.59M
Operating Income$ 33.25M$ 45.56M$ 16.77M$ -4.61M$ 14.02M
EBITDA$ 42.96M$ -113.83M$ 93.22M$ -79.79M$ 11.99M
Net Income$ 24.87M$ -96.95M$ 66.20M$ -73.63M$ 70.40M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 333.15M$ 321.92M$ 504.17M$ 500.06M$ 231.75M
Total Debt$ 0.00$ 0.00$ 1.22M$ 0.00$ 0.00
Net Debt$ -35.75M$ -77.04M$ -318.45M$ -320.73M$ -69.38M
Total Liabilities$ 57.38M$ 49.51M$ 90.77M$ 151.21M$ 111.59M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -18.26M$ -198.83M$ 580.00K$ -57.55M$ -26.04M
Operating Cash Flow$ 13.68M$ -145.73M$ 18.93M$ -39.48M$ 9.51M
Investing Cash Flow
Financing Cash Flow

Vistin Pharma ASA Earnings and Revenue History

Income Statement >

Vistin Pharma ASA Debt to Assets

Balance Sheet >

Vistin Pharma ASA Cash Flow

Cash Flow >

Vistin Pharma ASA Forecast EPS vs Actual EPS

Earnings >